Prognostic value of A/T/N biomarkers: Comparing plasma and imaging modalities in Alzheimer's disease

Key Points

• The study reveals that imaging modalities provide a stronger prognostic value compared to plasma biomarkers in Alzheimer's disease.
• Key evidence shows a significant difference in diagnostic accuracy, with imaging modalities outperforming plasma biomarkers in detecting neurodegeneration.
• Assessment using plasma and imaging modalities identifies A/T/N biomarkers as critical predictors of Alzheimer's progression across diverse populations.
• Findings highlight that while plasma biomarkers provide useful data, imaging modalities may offer superior insights into disease prognosis in Alzheimer’s patients.